Parkwood LLC Biogen Inc. Transaction History

Parkwood LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $16,537 - $20,881	78 Added 6.58%	1,264 $273,000
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $4,451 - $5,358	-20 Reduced 1.66%	1,186 $307,000
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $16,971 - $19,154	-67 Reduced 5.26%	1,206 $310,000
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $26,699 - $30,851	-97 Reduced 7.08%	1,273 $363,000
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $268,618 - $306,079	-1,047 Reduced 43.32%	1,370 $381,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $40,137 - $48,768	-159 Reduced 6.17%	2,417 $669,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $83,911 - $115,706	431 Added 20.09%	2,576 $688,000
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $402,273 - $478,377	2,145 New	2,145 $2,000

1,035

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.